Skip to main content
Equibles
AVLN logo

AVLN · Avalyn Pharma Inc.

Track AVLN — free

Use AVLN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about AVLN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$39.25 +2.67 (+7.30%) At close · Aug 14
Market Cap
$1.74B
Shares
44.33M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
No structured figures reported for this view yet.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 7.08×
EV/EBIT
—
Peer median 22.07×
P/E (TTM)
—
Peer median 16.80×

Peer medians compare against the 278 similar-size Biotechnology companies (of 545 listed).

Key facts CIK 1540171 CUSIP 05348Y105 13F (30d) 95 filings 93 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)